{"id":432611,"title":"Renewal of the Special Access Programme - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T08:29:06.388000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/renewal-special-access-programme.html?wbdisable=true","snippet":"Renewal of the Special Access Programme From Health Canada The Special Access Programme (SAP) is undergoing a renewal to make improvements to its processes. The SAP authorizes access to drugs that are not now authorized for sale in Canada, including drugs for rare diseases. This…","rawSnapshotUrl":"/api/snapshots/raw/432611","browseUrl":"https://replay.healtharchive.ca/job-6/20260102082906/https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/renewal-special-access-programme.html?wbdisable=true#ha_snapshot=432611","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}